Literature DB >> 21538812

Xenopus: An emerging model for studying congenital heart disease.

Erin Kaltenbrun1, Panna Tandon, Nirav M Amin, Lauren Waldron, Chris Showell, Frank L Conlon.   

Abstract

Congenital heart defects affect nearly 1% of all newborns and are a significant cause of infant death. Clinical studies have identified a number of congenital heart syndromes associated with mutations in genes that are involved in the complex process of cardiogenesis. The African clawed frog, Xenopus, has been instrumental in studies of vertebrate heart development and provides a valuable tool to investigate the molecular mechanisms underlying human congenital heart diseases. In this review, we discuss the methodologies that make Xenopus an ideal model system to investigate heart development and disease. We also outline congenital heart conditions linked to cardiac genes that have been well studied in Xenopus and describe some emerging technologies that will further aid in the study of these complex syndromes.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21538812      PMCID: PMC3125675          DOI: 10.1002/bdra.20793

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  276 in total

Review 1.  The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions.

Authors:  C K Qu
Journal:  Cell Res       Date:  2000-12       Impact factor: 25.617

2.  Delineation of two distinct 6p deletion syndromes.

Authors:  A F Davies; G Mirza; G Sekhon; P Turnpenny; F Leroy; F Speleman; C Law; N van Regemorter; E Vamos; F Flinter; J Ragoussis
Journal:  Hum Genet       Date:  1999-01       Impact factor: 4.132

3.  Epicardial control of myocardial proliferation and morphogenesis.

Authors:  Henry M Sucov; Ying Gu; Simmy Thomas; Peng Li; Mohammad Pashmforoush
Journal:  Pediatr Cardiol       Date:  2009-03-10       Impact factor: 1.655

Review 4.  Controlling morpholino experiments: don't stop making antisense.

Authors:  Judith S Eisen; James C Smith
Journal:  Development       Date:  2008-04-09       Impact factor: 6.868

5.  GATA4 transcription factor is required for ventral morphogenesis and heart tube formation.

Authors:  C T Kuo; E E Morrisey; R Anandappa; K Sigrist; M M Lu; M S Parmacek; C Soudais; J M Leiden
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

6.  Expression of the Mf1 gene in developing mouse hearts: implication in the development of human congenital heart defects.

Authors:  R E Swiderski; R S Reiter; D Y Nishimura; W L Alward; J W Kalenak; C S Searby; E M Stone; V C Sheffield; J J Lin
Journal:  Dev Dyn       Date:  1999-09       Impact factor: 3.780

7.  Distinct enhancers regulate skeletal and cardiac muscle-specific expression programs of the cardiac alpha-actin gene in Xenopus embryos.

Authors:  Branko V Latinkić; Brian Cooper; Norma Towers; Duncan Sparrow; Surendra Kotecha; Timothy J Mohun
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

8.  Development of the proepicardium in Xenopus laevis.

Authors:  Maike Jahr; Jan Schlueter; Thomas Brand; Jörg Männer
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

9.  Transmission of integrated sea urchin histone genes by nuclear transplantation in Xenopus laevis.

Authors:  L D Etkin; M Roberts
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

10.  HrT is required for cardiovascular development in zebrafish.

Authors:  Daniel P Szeto; Kevin J P Griffin; David Kimelman
Journal:  Development       Date:  2002-11       Impact factor: 6.868

View more
  23 in total

1.  A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression.

Authors:  Erin Kaltenbrun; Todd M Greco; Christopher E Slagle; Leslie M Kennedy; Tuo Li; Ileana M Cristea; Frank L Conlon
Journal:  J Proteome Res       Date:  2013-10-03       Impact factor: 4.466

Review 2.  Cardiac developmental toxicity.

Authors:  Gretchen J Mahler; Jonathan T Butcher
Journal:  Birth Defects Res C Embryo Today       Date:  2011-12

Review 3.  Cilia and coordination of signaling networks during heart development.

Authors:  Karen Koefoed; Iben Rønn Veland; Lotte Bang Pedersen; Lars Allan Larsen; Søren Tvorup Christensen
Journal:  Organogenesis       Date:  2013-12-17       Impact factor: 2.500

4.  An interspecies heart-to-heart: Using Xenopus to uncover the genetic basis of congenital heart disease.

Authors:  Alexandra MacColl Garfinkel; Mustafa K Khokha
Journal:  Curr Pathobiol Rep       Date:  2017-05-06

Review 5.  Xenopus as a model organism for birth defects-Congenital heart disease and heterotaxy.

Authors:  Anna R Duncan; Mustafa K Khokha
Journal:  Semin Cell Dev Biol       Date:  2016-02-22       Impact factor: 7.727

Review 6.  Expanding the genetic toolkit in Xenopus: Approaches and opportunities for human disease modeling.

Authors:  Panna Tandon; Frank Conlon; J David Furlow; Marko E Horb
Journal:  Dev Biol       Date:  2016-04-22       Impact factor: 3.582

7.  Tcf21 regulates the specification and maturation of proepicardial cells.

Authors:  Panna Tandon; Yana V Miteva; Lauren M Kuchenbrod; Ileana M Cristea; Frank L Conlon
Journal:  Development       Date:  2013-05-01       Impact factor: 6.868

8.  Preparation of developing Xenopus muscle for sarcomeric protein localization by high-resolution imaging.

Authors:  Chinedu U Nworu; Paul A Krieg; Carol C Gregorio
Journal:  Methods       Date:  2013-06-25       Impact factor: 3.608

9.  Proteomic profiling of cardiac tissue by isolation of nuclei tagged in specific cell types (INTACT).

Authors:  Nirav M Amin; Todd M Greco; Lauren M Kuchenbrod; Maggie M Rigney; Mei-I Chung; John B Wallingford; Ileana M Cristea; Frank L Conlon
Journal:  Development       Date:  2014-02       Impact factor: 6.868

10.  Congenital heart disease protein 5 associates with CASZ1 to maintain myocardial tissue integrity.

Authors:  Stephen Sojka; Nirav M Amin; Devin Gibbs; Kathleen S Christine; Marta S Charpentier; Frank L Conlon
Journal:  Development       Date:  2014-07-03       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.